The insider sales are small relative to market cap and partially explained by the CEO's option exercise and tax planning. No material signal for traders. Monitor upcoming earnings for any guidance changes, but this cluster alone does not warrant action.
ZLAB drugs
ZLAB drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 30 $19.00entry
- T+1 · 5mo ago +0.79%α +0.92% · $19.15
- T+5 · 4mo ago +0.42%α −0.18% · $19.08
- T+20 · 4mo ago −1.89%α −0.87% · $18.64
- T+60 · 8w ago +39.16%α +35.59% · $26.44
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Four Zai Lab insiders, including the CEO, CFO, and Chief Legal Officer, sold a total of ~$667K in open-market sales over a 7-day window. The CEO's sales ($559K) followed derivative exercises at $0 cost, suggesting a cash-out of vested options. The cluster is modest relative to ZLAB's $2.2B market cap (~0.03%), and the CEO's sales are partially explained by option exercise and tax planning. The cluster is a sell, but the dollar amount is trivial relative to market cap, and the CEO's sales follow non-cash derivative exercises, reducing the informational signal.
Key Financial Metrics
Key Facts
- Four insiders sold a total of ~$667K in open-market sales over a 7-day window (June 22-29, 2026).
- CEO Du Ying sold ~$559K total, including $130K on June 30, following derivative exercises of 35,940 shares at $0 cost on June 29.
- CFO Chen Yajing sold $40K and CLO Edmondson sold $72K on June 26, both small relative to market cap.
- Total insider sales represent ~0.03% of ZLAB's $2.2B market cap, well below the 0.1% materiality threshold.
- The CEO's sales follow non-cash derivative exercises, consistent with option cash-out and tax planning rather than a bearish signal.
Financial Impact
Total insider sales of ~$667K represent ~0.03% of ZLAB's $2.2B market cap, trivial and routine.
Risk Factors
- CEO sold ~$559K total, which could be misinterpreted as a bearish signal by the market.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ZLAB-1782977169619 |
Track record
23 reports on ZLAB
3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.13% at T+20 after the May 7, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $22.60 to $25.48 Now $23.47 +3.85% ▲ +12.74% +12.43% vs SPY
- Oct 23, 202624d ago 8-K Bullish 6/10 Entry $24.03 to $24.34 Now $23.47 −2.33% ▲ +1.29% +0.58% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $25.64 to $26.17 Now $23.47 −8.46% ▲ +2.07% +1.75% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 12, 202613w ago 144 Neutral 2/10 Entry $25.49 to $26.03 Now $23.47 −7.92% ▲ +2.12% +1.42% vs SPY
- Jul 1, 202619w ago Insider Cluster Neutral 2/10 Entry $19.12 to $19.08 Now $23.47 +22.75% ▼ −0.21% −1.08% vs SPY
- Jun 29, 202620w ago Insider Cluster Neutral 3/10 Viewing Entry $19.00 to $19.15 Now $23.47 +23.53% ▲ +0.79% +0.92% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 5/10 Entry $17.64 to $17.07 Now $23.47 −33.05% ▲ +3.23% +3.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers